Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Carbone

Showing results (91-100 of 283) with videos related to

Pageof 29
Sort By:
Molecular Cancer Therapeutics|October 29, 2017
Histone Deacetylase Inhibition Enhances the Antitumor Activity of a MEK Inhibitor in Lung Cancer Cells Harboring <i>RAS</i> MutationsTadaaki Yamada, Joseph M Amann, Azusa Tanimoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 10, 2017
Lung Cancer Patients with Germline Mutations Detected by Next-Generation Sequencing and/or Liquid BiopsyTakehito Shukuya, Sandipkumar Patel, Kate Shane-Carson, et al.
Cancer Research|October 5, 2006
Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonismLi Yang, Yuhui Huang, Rut Porta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2004
Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiationMikhail M Dikov, Joyce E Ohm, Neelanjan Ray, et al.
Cancer Research|October 16, 2003
Genetic blockade of the insulin-like growth factor-I receptor: a promising strategy for human pancreatic cancerYongfen Min, Yasushi Adachi, Hiroyuki Yamamoto, et al.
Neoplasia (New York, N.Y.)|October 27, 2011
Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell linesSunil K Halder, Yong-Jig Cho, Arunima Datta, et al.
Frontiers in Oncology|October 5, 2020
Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab vs. Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung CancerHuabin Hu, Longjiang She, Mengting Liao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 7, 2016
Relationship between Overall Survival and Response or Progression-Free Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with Anti-PD-1/PD-L1 AntibodiesTakehito Shukuya, Keita Mori, Joseph M Amann, et al.
Cancer Science|November 3, 2011
Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancersHirokazu Ohashi, Yasushi Adachi, Hiroyuki Yamamoto, et al.
Clinical Lung Cancer|May 18, 2012
Identifying barriers associated with enrollment of patients with lung cancer into clinical trialsLeora Horn, Vicki L Keedy, Norma Campbell, et al.
Pageof 29

Showing results (91-100 of 283) with videos related to

Sort By:
Pageof 29
Molecular Cancer Therapeutics|October 29, 2017
Histone Deacetylase Inhibition Enhances the Antitumor Activity of a MEK Inhibitor in Lung Cancer Cells Harboring <i>RAS</i> MutationsTadaaki Yamada, Joseph M Amann, Azusa Tanimoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 10, 2017
Lung Cancer Patients with Germline Mutations Detected by Next-Generation Sequencing and/or Liquid BiopsyTakehito Shukuya, Sandipkumar Patel, Kate Shane-Carson, et al.
Cancer Research|October 5, 2006
Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonismLi Yang, Yuhui Huang, Rut Porta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2004
Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiationMikhail M Dikov, Joyce E Ohm, Neelanjan Ray, et al.
Cancer Research|October 16, 2003
Genetic blockade of the insulin-like growth factor-I receptor: a promising strategy for human pancreatic cancerYongfen Min, Yasushi Adachi, Hiroyuki Yamamoto, et al.
Neoplasia (New York, N.Y.)|October 27, 2011
Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell linesSunil K Halder, Yong-Jig Cho, Arunima Datta, et al.
Frontiers in Oncology|October 5, 2020
Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab vs. Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung CancerHuabin Hu, Longjiang She, Mengting Liao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 7, 2016
Relationship between Overall Survival and Response or Progression-Free Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with Anti-PD-1/PD-L1 AntibodiesTakehito Shukuya, Keita Mori, Joseph M Amann, et al.
Cancer Science|November 3, 2011
Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancersHirokazu Ohashi, Yasushi Adachi, Hiroyuki Yamamoto, et al.
Clinical Lung Cancer|May 18, 2012
Identifying barriers associated with enrollment of patients with lung cancer into clinical trialsLeora Horn, Vicki L Keedy, Norma Campbell, et al.
Pageof 29